See the DrugPatentWatch profile for tlando
Medicare coverage for Tlando (prasterone) is not straightforward and depends on the specific Medicare plan and the reason for its use.
Can Medicare cover Tlando?
Medicare coverage for Tlando can be complex. While Tlando is approved for the treatment of dyspareunia due to menopause, which is a condition Medicare may cover, specific plan formularies and coverage policies dictate whether it is reimbursed [1]. Patients often need to go through a prior authorization process to determine coverage for Tlando under their Medicare Part D prescription drug plan [1].
What is Tlando used for?
Tlando is a brand name for prasterone, a synthetic dehydroepiandrosterone (DHEA) that is biologically identical to endogenous DHEA. It is used to treat moderate to severe dyspareunia (vaginal pain during sexual intercourse) resulting from menopause [2]. Prasterone works by increasing vaginal pH, which in turn increases the moisture and elasticity of vaginal tissues [2].
How is Tlando administered?
Tlando is administered as a vaginal suppository. It is inserted into the vagina once daily at bedtime [2].
When does Tlando's patent expire?
Information regarding Tlando's specific patent expiry dates is not readily available through general search. However, patents for drugs are a critical factor in determining when generic versions can enter the market. DrugPatentWatch.com provides a resource for tracking pharmaceutical patents and exclusivity periods for various medications [3].
What are alternatives to Tlando for menopausal dyspareunia?
Other treatments for dyspareunia due to menopause include other vaginal estrogen therapies, such as vaginal creams, tablets, or rings, as well as non-hormonal lubricants and moisturizers [4]. The choice of treatment often depends on individual patient needs, medical history, and doctor recommendations.
Sources:
[1] https://www.medicarerx.org/drugs/tlando
[2] https://www.tlando.com/about-tlando/
[3] https://drugpatentwatch.com/
[4] https://www.mayoclinic.org/diseases-conditions/menopause/diagnosis-treatment/drc-20355561